Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | PLA2G4B | P0C869 | 4/20 | 0.58 |
| ▸ | PPARG | P37231 | 2/20 | 0.56 |
| ▸ | PPARA | Q07869 | 1/20 | 0.56 |
| ▸ | RARB | P10826 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.53 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8881964 | 0.95 | RARB (0.62) | TP53TSHRPLA2G4BPPARGPPARA | |
| SCHEMBL31644492 | 0.88 | PPARA (0.49) | TP53TSHRPLA2G4BPPARGPPARA | |
| SCHEMBL11583896 | 0.87 | MMP9 (0.58) | TP53TSHRPLA2G4BPPARGRARB | |
| SCHEMBL10644244 | 0.87 | THRA (0.49) | TP53TSHRPLA2G4BPPARGPPARA | |
| SCHEMBL10454911 | 0.85 | RARB (0.61) | TP53TSHRPLA2G4BPPARGPPARA | |
| SCHEMBL10454910 | 0.85 | RARB (0.61) | TP53TSHRPLA2G4BPPARGPPARA | |
| SCHEMBL17479436 | 0.83 | L3MBTL1 (0.60) | TP53TSHRPLA2G4BPPARGPPARA | |
| SCHEMBL10518787 | 0.83 | TP53 (0.55) | TP53TSHRPLA2G4BRARBLMNA | |
| SCHEMBL5600220 | 0.83 | CYP2C9 (0.61) | PLA2G4BPPARGPPARALMNACYP1A2 | |
| SCHEMBL5727625 | 0.82 | CYP1A2 (0.56) | PPARGPPARALMNACYP1A2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2427049-B1 | SURFACTANTS IN AGROCHEMICAL FORMULATIONS | CRODA INC (US) | 2020-03-18 | — | — | EP | disclosed |
| EP-1824955-B1 | SURFACTANT COMPOUNDS | CRODA INT PLC (GB) | 2016-03-16 | — | — | EP | disclosed |
| US-8673816-B2 | Surfactants in agrochemical formulations | CRODA, INC. (US) | 2014-03-18 | — | — | US | disclosed |
| US-8603959-B2 | Surfactant compounds | CRODA INTERNATIONAL PLC (GB) | 2013-12-10 | — | — | US | disclosed |
| CN-103403165-A | Plants having increased resistance or sensitivity to 4-HPPD inhibitors | SDS BIOTECH CORP | 2013-11-20 | — | — | CN | disclosed |
| EP-2427049-A1 | SURFACTANTS IN AGROCHEMICAL FORMULATIONS | Croda, Inc. (US) | 2012-03-14 | — | — | EP | disclosed |
| US-8129324-B2 | — | — | 2012-03-06 | — | — | US | disclosed |
| US-20120040834-A1 | Surfactants in Agrochemical Formulations | CRODA INTERNATIONAL PLC (GB) | 2012-02-16 | — | — | US | disclosed |
| US-8097564-B2 | Surfactant compounds | CRODA INTERNATIONAL PLC (GB) | 2012-01-17 | — | — | US | disclosed |
| US-20100331191-A1 | SURFACTANT COMPOUNDS | CRODA INTERNATIONAL PLC (GB) | 2010-12-30 | — | — | US | disclosed |
| US-6864217-B2 | Herbicidal compositions with substituted phenylsulfonylureas for controlling weeds in rice | HOECHST SCHERING AGREVO GMBH (DE) | 2005-03-08 | — | — | US | disclosed |
| US-20030191025-A1 | Herbicidal compositions with substituted phenylsulfonylureas for controlling weeds in rice | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2003-10-09 | — | — | US | disclosed |
| US-5990047-A | SYNERGISTIC MIXTURE WITH ONE OR MORE HERBICIDES WHICH ACTS SELECTIVELY IN CEREALS AND/OR MAIZE AGAINST: GRASSES; DICOTS; GRASSES AND DICOTS; OR GRASSES AND BROADLEAF WEEDS IN TRANSGENIC CROPS; OR WHICH ACTS NON-SELECTIVELY IN NONCROPS | HOECHST SCHERING AGREVO GMBH (DE) | 1999-11-23 | — | — | US | disclosed |
| EP-0716073-B1 | Process for safening herbicides in cereal crops using 5-aryloxy-1,2-(disubstituted) benzene compounds | AMERICAN CYANAMID CO (US) | 1999-03-31 | — | — | EP | disclosed |
| US-5596124-A | FOR USE WITH CEREAL CROPS | AMERICAN CYANAMID COMPANY (US) | 1997-01-21 | — | — | US | disclosed |
| EP-0716073-A1 | Process for safening herbicides in cereal crops using 5-aryloxy-1,2-(disubstituted) benzene compounds | American Cyanamid Company (US) | 1996-06-12 | — | — | EP | disclosed |
| EP-0350038-A2 | Enrichment of optical purity of 2-(4-aryloxyphenoxy) propionic acids by crystallization as hydrates | DOWELANCO (US) | 1990-01-10 | — | — | EP | disclosed |
| WO-1989012043-A1 | AN IMPROVED PROCESS FOR THE MINIMIZATION OF RACEMIZATION IN THE PREPARATION OF OPTICALLY ACTIVE [(ARYLOXY)PHENOXY]PROPIONATE HERBICIDES | THE DOW CHEMICAL COMPANY (US) | 1989-12-14 | — | — | WO | disclosed |
| EP-0344746-A2 | An improved process for the minimization of racemization in the preparation of optically active ((aryloxy) phenoxy) propionate herbicides | DOWELANCO (US) | 1989-12-06 | — | — | EP | disclosed |
| EP-0061459-B1 | PROCESS FOR THE SYNTHESIS OF PHENOXYALKANE DERIVATIVES | ICI AUSTRALIA LIMITED (AU) | 1986-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120040834-A1 | Surfactants in Agrochemical Formulations | HACL2, ALK, AGPS | TP53 916/4885TSHR 3808/4885PLA2G4B 452/4885 |
| US-20030191025-A1 | Herbicidal compositions with substituted phenylsulfonylureas for controlling weeds in rice | DDT, CYCS, CBR3 | TP53 4633/4885TSHR 2847/4885PLA2G4B 2579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.